147 related articles for article (PubMed ID: 12318228)
1. [Disadvantages of third generation progestins].
Sitruk-ware R
Contracept Fertil Sex (Paris); 1993 Apr; 21(4):295-300. PubMed ID: 12318228
[TBL] [Abstract][Full Text] [Related]
2. [Third generation progestagens].
Belaisch J; Eliakim V
Contracept Fertil Sex (Paris); 1993 Apr; 21(4):287-93. PubMed ID: 12318226
[TBL] [Abstract][Full Text] [Related]
3. [Side effects of third generation progestagens].
Sitruk-ware R
Contracept Fertil Sex (Paris); 1993 Apr; 21(4):295-300. PubMed ID: 12318229
[TBL] [Abstract][Full Text] [Related]
4. [Oral contraception: advantages of estrogen reduction].
Cohen J
Contracept Fertil Sex (Paris); 1993 Jun; 21(6):489-94. PubMed ID: 12318239
[TBL] [Abstract][Full Text] [Related]
5. [Metabolic impact of current estrogen-progestins and cardiovascular consequences].
Gaspard U; Lambotte R
Bull Mem Acad R Med Belg; 1991; 146(8-10):334-42; discussion 342-5. PubMed ID: 1815814
[TBL] [Abstract][Full Text] [Related]
6. [Thirty years after the appearance of the first oral contraceptive, clinical and biological analysis of a new estrogen-progestin combination, a three phase pill containing gestodene].
Belaisch J; Hommais-loufrani B
Fertil Contracept Sex; 1988 Apr; 16(4 Suppl):1-8. PubMed ID: 12342078
[TBL] [Abstract][Full Text] [Related]
7. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
Gaspard U; Dubois M
Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606
[TBL] [Abstract][Full Text] [Related]
8. [Progestins and arterial disease].
Rozenbaum H
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):344-52. PubMed ID: 12280205
[TBL] [Abstract][Full Text] [Related]
9. [Oral contraception: disadvantages of estrogen reduction].
Denis C
Contracept Fertil Sex (Paris); 1993 Jun; 21(6):481-8. PubMed ID: 12318238
[TBL] [Abstract][Full Text] [Related]
10. [Combined estrogen-progestagen contraception and glucid and water-sodium metabolism].
Belaisch J; Hommais-loufrani B
Contracept Fertil Sex (Paris); 1988 Feb; 16(2):3-7. PubMed ID: 12342001
[TBL] [Abstract][Full Text] [Related]
11. [Metrorrhagia caused by estrogen-progestin combinations].
Erny R; Erny N
Contracept Fertil Sex (Paris); 1994 Feb; 22(2):93-7. PubMed ID: 12319056
[TBL] [Abstract][Full Text] [Related]
12. [The latest progestagens].
Belaisch J; Eliakim V
Contracept Fertil Sex (Paris); 1993 Apr; 21(4):287-93. PubMed ID: 12318227
[TBL] [Abstract][Full Text] [Related]
13. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of the new progestogens in combination oral contraceptives.
Rebar RW; Zeserson K
Contraception; 1991 Jul; 44(1):1-10. PubMed ID: 1832625
[TBL] [Abstract][Full Text] [Related]
15. [Current issues in contraception].
Audebert AJ
Contracept Fertil Sex (Paris); 1985 Feb; 13(2):467-73. PubMed ID: 12339971
[TBL] [Abstract][Full Text] [Related]
16. OC practice guidelines: minimizing side effects.
Darney PD
Int J Fertil Womens Med; 1997; Suppl 1():158-69. PubMed ID: 9168375
[TBL] [Abstract][Full Text] [Related]
17. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
[TBL] [Abstract][Full Text] [Related]
18. [Side effects of third generation progestins].
Sitruk-Ware R
Contracept Fertil Sex; 1993 Apr; 21(4):295-300. PubMed ID: 7951629
[TBL] [Abstract][Full Text] [Related]
19. Comparative pharmacology of newer progestogens.
Kuhl H
Drugs; 1996 Feb; 51(2):188-215. PubMed ID: 8808163
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of the androgenicity of progestins in hormonal therapy in women.
Linn ES
Clin Ther; 1990; 12(5):447-55. PubMed ID: 2268868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
